GSK’s high-lev­el man­age­ment makeover con­tin­ues as CEO Em­ma Walm­s­ley over­sees chang­ing of the guard

The big shake­up in the in­ner ex­ec­u­tive cir­cle around CEO Em­ma Walm­s­ley is con­tin­u­ing to­day, with two top ap­point­ments at Glax­o­SmithK­line — and one key ex­it.

Luc De­bruyne is out at the end of this year as pres­i­dent of vac­cines af­ter a 5-year stint. Roger Con­nor, who runs glob­al man­u­fac­tur­ing and sup­ply, takes that role Sep­tem­ber 1. Reg­is Simard is be­ing ap­point­ed pres­i­dent, phar­ma­ceu­ti­cal sup­ply chain, and will join the cor­po­rate ex­ec­u­tive team.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER